Company Monitoring Page for Novartis

latest headlines for company on cafepharma

#ASCO21: Novartis keeps building out survival data for Kisqali, hoping to keep the pressure on Pfizer's Ibrance
Endpoints
Thu, 06/3/21 - 12:09 am
Tags:
ASCO 2021, Novartis, Kisqali, breast cancer
GlaxoSmithKline scores a big win in Zofran litigation after FDA repeatedly rejects pregnancy warning
Fierce Pharma
Wed, 06/2/21 - 11:04 am
Tags:
GSK, Novartis, Zofran, pregnancy
Novartis stakes another PhIII win for Cosentyx, goes deeper into pediatric markets
Endpoints
Wed, 06/2/21 - 10:54 am
Tags:
Novartis, Cosentyx, juvenile idiopathic arthritis
Novartis plots 'next frontier' of MS treatment — and it could spell a buyout for a small Swiss player
Endpoints
Tue, 06/1/21 - 11:10 am
Tags:
Novartis, MS, multiple sclerosis, CLS12311, Cellerys
Novartis halts three trials of Beovu eye drug on safety concerns
Pharmaforum
Tue, 06/1/21 - 11:03 am
Tags:
Novartis, clinical trials, Beovu, wet age-related macular degeneration
Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech
Fierce Biotech
Wed, 05/19/21 - 10:31 am
Tags:
Novartis, gene therapy, Tevard Biosciences
Novartis' Sandoz embarks on €150M antibiotics manufacturing upgrade in Europe
Fierce Pharma
Tue, 05/18/21 - 11:01 am
Tags:
Novartis, Sandoz, generics, Europe, drug manufacturing
Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein
Fierce Pharma
Mon, 05/17/21 - 10:59 pm
Tags:
Novartis, Sandoz, generics, Supreme Court, Amgen, Embrel, biosimilar
ACC 2021: Novartis looks for silver linings in Entrestro’s narrow loss to an ACE inhibitor in heart attack patients
Fierce Pharma
Sat, 05/15/21 - 11:00 pm
Tags:
ACC, Novartis, Entresto, heart failure
Biopharma Companies Wrestle with Staffing Situations and Shortages from Pandemic
BioSpace
Thu, 04/29/21 - 10:45 pm
Tags:
COVID-19, pandemic, Sanofi, Pfizer, Moderna Therapeutics, Novartis, Lonza
Zolgensma flatlines, but Spinraza isn’t the beneficiary
EP Vantage
Wed, 04/28/21 - 10:27 am
Tags:
SMA, Biogen, Novartis, Roche, Spinraza, Zolgensma, Evrysdi
Novartis Generics Face 'Challenging Quarter,' But Gene Therapy Shines
Investors Business Daily
Tue, 04/27/21 - 11:20 pm
Tags:
Novartis, earnings
Now reimag­in­ing home, of­fice sched­ules: No­var­tis CEO Vas Narasimhan sees a new nor­mal in the post-Covid era
Endpoints
Tue, 04/27/21 - 10:56 am
Tags:
Novartis, Vas Narasimhan, pandemic
Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra
Fierce Pharma
Thu, 04/15/21 - 11:21 am
Tags:
Novartis, COVID-19, Pfizer, BioNTech, CureVac, Roche, API, Actemra
Genentech and Novartis Win FDA Approval for Self-Injectable Form of Xolair
BioSpace
Tue, 04/13/21 - 10:03 pm
Tags:
Genentech, Novartis, FDA, Xolair, allergies
Novartis expands in radio-oncology again with $1.3bn Artios alliance
Pharmaforum
Wed, 04/7/21 - 10:35 am
Tags:
Novartis, radioligands, Artios Pharma, precision medicine, radio-oncology
Novartis dives even deeper into radioligands, notching licensing deal with iTheranostics for multiple compounds
Endpoints
Tue, 03/30/21 - 11:40 am
Tags:
Novartis, radioligands, iTheranostics
Novartis pushes back on chairman's 'inaccurate and inconsistent' comments undermining bribery settlement
Endpoints
Fri, 03/26/21 - 10:54 am
Tags:
Novartis, bribery, physicians, DOJ, kickbacks
Novartis is shutting down Colorado plant, laying off 400 employees after overestimating gene therapy demand
Fierce Pharma
Thu, 03/25/21 - 11:18 am
Tags:
Novartis, gene therapy, layoffs, Colorado, drug manufacturing
Novartis' radioligand hits goal in phase 3 prostate cancer trial
Fierce Biotech
Tue, 03/23/21 - 10:29 am
Tags:
Novartis, radioligand, 177Lu-MSMA-617, prostate cancer, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.